08/07/2026 | Press release | Distributed by Public on 08/07/2026 19:36
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Options (Right to Purchase)(9) | $1.41 | 08/05/2026 | M | 7,941 | (10) | 10/07/2029 | Common Stock | 7,941 | $1.41 | 732,859(11) | D | ||||
| Stock Options (Right to Purchase)(9) | $1.41 | 08/06/2026 | M | 50,000 | (10) | 10/07/2029 | Common Stock | 50,000 | $1.41 | 682,859(11) | D | ||||
| Stock Options (Right to Purchase)(9) | $3.16 | 08/06/2026 | M | 50,000 | (12) | 12/09/2030 | Common Stock | 50,000 | $3.16 | 810,395(11) | D | ||||
| Stock Options (Right to Purchase)(9) | $1.41 | 08/07/2026 | M | 50,000 | (10) | 10/07/2029 | Common Stock | 50,000 | $1.41 | 632,859(11) | D | ||||
| Stock Options (Right to Purchase)(9) | $3.16 | 08/07/2026 | M | 50,000 | (12) | 12/09/2030 | Common Stock | 50,000 | $3.16 | 760,395(11) | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Walsh Mark T. C/O SAVERS VALUE VILLAGE, INC. 11400 SE 6TH, SUITE 125 BELLEVUE, WA 98004 |
X | CEO & Director | ||
| /s/ Richard Medway, attorney in fact | 08/07/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. |
| (2) | This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.00 to $11.09. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| (3) | This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.3850 to $11.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| (4) | This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.50 to $11.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| (5) | This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.05 to $12.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| (6) | This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.06 to $12.67. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| (7) | This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.05 to $12.05. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| (8) | This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.07 to $12.63. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| (9) | Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. |
| (10) | The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. |
| (11) | The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately. |
| (12) | The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. |